# Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease

> **NCT00115336** · PHASE4 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 10 (actual)

## Conditions studied

- Hematologic Diseases
- Anemia, Sickle Cell

## Interventions

- **DRUG:** Intravenous Ketorolac
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT00115336
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2008-08
- **Final completion:** 2008-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115336, "Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00115336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*